Christian Lambiase

Dr. Christian Lambiase

Gastrointestinal Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Tuscany, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2023 in Techniques in Coloproctology
Verified
Journal Article
Closed access
PDF file
EFE. Falletto
E. Falletto
JMJ. Martellucci
J. Martellucci
PRP. Rossitti
P. Rossitti
ABA. Bondurri
A. Bondurri
GZG. Zaffaroni
G. Zaffaroni
EZE. Zucchi
E. Zucchi

30 June 2023 in Digestive and Liver Disease
Verified
Journal Article
Closed access
GCGiuseppe Chiarioni
Giuseppe Chiarioni
CLChristian Lambiase
Christian Lambiase
WWWilliam E. Whitehead
William E. Whitehead
FRFrancesco Rettura
Francesco Rettura
RMRiccardo Morganti
Riccardo Morganti
MBMassimo Bellini
Massimo Bellini

23 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
ETEmanuele Tumino
Emanuele Tumino
Pierfrancesco VisaggiPierfrancesco Visaggi
Pierfrancesco Visaggi
VBValeria Bolognesi
Valeria Bolognesi
LCLinda Ceccarelli
Linda Ceccarelli
CLChristian Lambiase
Christian Lambiase
EMEmanuele Marciano
Emanuele Marciano
Lower gastrointestinal endoscopy is considered the gold standard for the diagnosis and removal of colonic polyps. Delays in colonoscopy following a positive fecal immunochemical test increase the likelihood of advanced adenomas and colorectal cancer (CRC) occurrence. However, patients may refuse to undergo conventional colonoscopy (CC) due to fear of possible risks and pain or discomfort. In this regard, patients undergoing CC frequently require sedation to better tolerate the procedure, increasing the risk of deep sedation or other complications related to sedation. Accordingly, the use of CC as a first-line screening strategy for CRC is hampered by patients’ reluctance due to its invasiveness and anxiety about possible discomfort. To overcome the limitations of CC and improve patients’ compliance, several studies have investigated the use of robotic colonoscopy (RC) both in experimental models and in vivo. Self-propelling robotic colonoscopes have proven to be promising thanks to their peculiar dexterity and adaptability to the shape of the lower gastrointestinal tract, allowing a virtually painless examination of the colon. In some instances, when alternatives to CC and RC are required, barium enema (BE), computed tomographic colonography (CTC), and colon capsule endoscopy (CCE) may be options. However, BE and CTC are limited by the need for subsequent investigations whenever suspicious lesions are found. In this narrative review, we discussed the current clinical applications of RC, CTC, and CCE, as well as the advantages and disadvantages of different endoscopic procedures, with a particular focus on RC.

5 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GSGiusi Desirè Sciumè
Giusi Desirè Sciumè
GBGinevra Berti
Ginevra Berti
CLChristian Lambiase
Christian Lambiase
IPItalia Paglianiti
Italia Paglianiti
VVVincenzo Villanacci
Vincenzo Villanacci
Massimo BelliniMassimo Bellini
Massimo Bellini
Irritable bowel syndrome with predominant diarrhea (IBS-D) and functional diarrhea (FD) are disorders of gut–brain interaction characterized by recurring symptoms which have a serious impact on the patient’s quality of life. Their pathophysiology is far from being completely understood. In IBS-D growing evidence suggests that bile acid malabsorption (BAM) could be present in up to 30% of patients. Microscopic colitis (MC) is a well-known cause of watery diarrhea and some patients, at first, can be diagnosed as IBS-D or FD. Both BAM and MC are often responsible for the lack of response to conventional treatments in patients labelled as “refractory”. Moreover, because BAM and MC are not mutually exclusive, and can be found in the same patient, they should always be considered in the diagnostic workout when a specific treatment for BAM or MC is unsatisfactory. In the present review the possible shared pathogenetic mechanisms between BAM and MC are discussed highlighting how MC can induce a secondary BAM. Moreover, a brief overview of the current literature regarding the prevalence of their association is provided.

25 October 2024 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
CLChristian Lambiase
Christian Lambiase
MBMassimo Bellini
Massimo Bellini
WWWilliam E. Whitehead
William E. Whitehead
SPStefan Lucian Popa
Stefan Lucian Popa
RMRiccardo Morganti
Riccardo Morganti
GCGiuseppe Chiarioni
Giuseppe Chiarioni
Background: Functional defecation disorders (FDD) are a common etiology of refractory chronic constipation (CC). FDD diagnosis (dyssynergic defecation [DD] and inadequate defecatory propulsion [IDP]), requires diagnostic tests including anorectal manometry (ARM) and balloon expulsion test (BET). Biofeedback (BF) is the treatment of choice for DD. The aims of our study were to evaluate: the outcome of BF in a group of constipated patients with defecatory disorders of any etiology; the efficacy of two simple diagnostic tools in predicting BF outcome in the short‐term.Methods: One hundred and thirty‐one refractory CC patients failing the BET underwent BF therapy. Before BF, all patients underwent the following: ARM. Straining questionnaire. The answers were: “belly muscles”; “anal muscles”; “both”; “Don't know/No answer.” Digital rectal examination augmented by abdominal palpation on straining (augmented‐DRE). The BF therapist was blinded to ARM, straining questionnaire, and augmented‐DRE results.Key Results: Eighty‐one patients responded to BF. Gender, age, and IBS‐C showed no significant impact on BF response. Both DD and IDP responded equally to BF, while the rate of response in patients with isolated structural pelvic floor abnormalities was lower (p < 0.001). The answer “anal muscles” to straining questionnaire showed a strong association with BF response (p < 0.001). A lack in abdominal contraction and in anal relaxation on augmented‐DRE were strongly associated with BF response (p < 0.01). Absence of manual maneuvers to facilitate defecation was associated with BF response (p < 0.001).Conclusions & Inferences: BF is the therapy of choice for refractory constipation due to FDD of any etiology, inducing both clinical and anorectal physiology improvement in the short term. Comorbid IBS‐C did not affect outcome while symptomatic isolated pelvic floor abnormalities appeared refractory to behavior treatment.The straining questionnaire and augmented‐DRE outcomes showed a strong correlation with BF response and can be implemented in clinical practice to improve the management of constipated patients by prompting early referral to BF.

5 April 2023 in Best Practice & Research Clinical Gastroenterology
Verified
Journal Article
Open access
FRFrancesco Rettura
Francesco Rettura
CLChristian Lambiase
Christian Lambiase
AGAntonio Grosso
Antonio Grosso
ARAlessandra Rossi
Alessandra Rossi
RTRiccardo Tedeschi
Riccardo Tedeschi
MBMassimo Bellini
Massimo Bellini
Functional dyspepsia (FD) is a frequent disorder of gut-brain interaction, affecting 5-7% of people globally, with significant impairment in quality of life. The management of FD is challenging due to the lack of specific therapeutic approaches. Although food seems to play a role in symptom production, its pathophysiologic role in patients with FD is not fully understood. Most FD patients report that their symptoms are triggered by food, especially in the post-prandial distress syndrome (PDS) group, although evidence to support the use of dietary interventions are limited. FODMAPs can increase production of gas in the intestinal lumen, through fermentation by intestinal bacteria, can exert osmotic effects by increasing water volume and can cause an excessive production of short-chain fatty acids (propionate, butyrate, and acetate). Emerging scientific evidence, confirmed by recent clinical trials, suggest that FODMAPs could be involved in the pathogenesis of FD. Given the consolidated approach of the Low-FODMAP Diet (LFD) in irritable bowel syndrome (IBS) management and emerging scientific evidence regarding the LFD in FD, a therapeutic role of this diet may be hypothesized also in FD, either alone or in combination with other therapies.